Combination therapy targets genetic mutation found in many cancers

Via Top Health News -- ScienceDaily

A study has shown promise for effective treatment of therapy-resistant cancers caused by a mutation of the RAS gene found in many cancers. The pre-clinical study combined therapies targeting the inhibitors polyADP ribose polymerase (PARP) and mitogen-activated protein kinase (MEK).

View original post here:

%d bloggers like this: